The Impact of Early Changes in Albumin Levels on Long-Term Kidney and Mortality Outcomes in Patients With Acute Kidney Injury Undergoing Continuous Kidney Replacement Therapy

OBJECTIVES: To investigate the association between early changes in the levels of serum albumin during continuous kidney replacement therapy (CKRT) and long-term dialysis dependence and mortality in patients with acute kidney injury who survived for 90 days or more days after CKRT initiation. DESIGN: A multicenter retrospective cohort study. SETTING: Eight university-affiliated tertiary hospitals in South Korea participating in the LINking health medical records, biospecimens, and biosignals in Korean patients with Acute kidney injury consortium cohort. PATIENTS: The study involved 1087 adult patients with acute kidney injury who survived for 90 or more days after CKRT initiation between January 2017 and June 2022. INTERVENTIONS: None. MEASUREMENTS AND MAIN RESULTS: Based on albumin levels at CKRT initiation and on day 7, patients were categorized into the persistent, resolved, new-onset, and no hypoalbuminemia groups. A composite of progression to end-stage kidney disease and all-cause mortality within 365 days was the primary outcome. The composite outcome occurred in 33.4% (363/1087) of the patients. The adjusted odds ratio (aOR) for the primary outcome was significantly higher in all groups when compared with the no hypoalbuminemia group (persistent: aOR, 2.64; 95% CI, 1.73-4.04; p < 0.001; resolved: aOR, 2.27; 95% CI, 1.38-3.75; p < 0.001; new-onset: aOR, 1.68; 95% CI, 1.06-2.68; p = 0.028). No hypoalbuminemia group was associated with the most favorable prognosis, whereas persistent hypoalbuminemia was associated with the worst outcomes. CONCLUSIONS: During CKRT, early albumin level changes are associated with long-term kidney failure and mortality risk. Persistent hypoalbuminemia predicts the worst outcomes. Even in patients without baseline hypoalbuminemia, early decline in albumin is associated with worse prognosis.

Authors

Institutions

Publication Details

Journal
Critical Care Medicine
Published
2026-11-13
DOI
https://doi.org/10.1097/ccm.0000000000007408
Primary Topic
Acute Kidney Injury Research
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

The Impact of Early Changes in Albumin Levels on Long-Term Kidney and Mortality Outcomes in Patients With Acute Kidney Injury Undergoing Continuous Kidney Replacement Therapy

Seung Seok Han, Jeong‐Hoon Lim, Sungjin Chung, Kyubok Jin et al.
Critical Care Medicine
Acute Kidney Injury Research
article

The Impact of Early Changes in Albumin Levels on Long-Term Kidney and Mortality Outcomes in Patients With Acute Kidney Injury Undergoing Continuous Kidney Replacement Therapy

Seung Seok Han, Jeong‐Hoon Lim, Sungjin Chung, Kyubok Jin, Jang-Hee Cho, Gang-Jee Ko, Jung Nam An, You Hyun Jeon, Hee‐Yeon Jung, Jung Pyo, Chan-Duck Kim, Yu Jin Seo, Dong Ki Kim, Jeonghwan Lee, Yong-Lim Kim, Minsang Kim, Sejoong Kim, Sung Gyun Kim, Ji-Young Choi, Sun-Hee Park, Yena Jeon, Junyoung Park, Yaerim Kim
article en

Abstract

OBJECTIVES: To investigate the association between early changes in the levels of serum albumin during continuous kidney replacement therapy (CKRT) and long-term dialysis dependence and mortality in patients with acute kidney injury who survived for 90 days or more days after CKRT initiation. DESIGN: A multicenter retrospective cohort study. SETTING: Eight university-affiliated tertiary hospitals in South Korea participating in the LINking health medical records, biospecimens, and biosignals in Korean patients with Acute kidney injury consortium cohort. PATIENTS: The study involved 1087 adult patients with acute kidney injury who survived for 90 or more days after CKRT initiation between January 2017 and June 2022. INTERVENTIONS: None. MEASUREMENTS AND MAIN RESULTS: Based on albumin levels at CKRT initiation and on day 7, patients were categorized into the persistent, resolved, new-onset, and no hypoalbuminemia groups. A composite of progression to end-stage kidney disease and all-cause mortality within 365 days was the primary outcome. The composite outcome occurred in 33.4% (363/1087) of the patients. The adjusted odds ratio (aOR) for the primary outcome was significantly higher in all groups when compared with the no hypoalbuminemia group (persistent: aOR, 2.64; 95% CI, 1.73-4.04; p < 0.001; resolved: aOR, 2.27; 95% CI, 1.38-3.75; p < 0.001; new-onset: aOR, 1.68; 95% CI, 1.06-2.68; p = 0.028). No hypoalbuminemia group was associated with the most favorable prognosis, whereas persistent hypoalbuminemia was associated with the worst outcomes. CONCLUSIONS: During CKRT, early albumin level changes are associated with long-term kidney failure and mortality risk. Persistent hypoalbuminemia predicts the worst outcomes. Even in patients without baseline hypoalbuminemia, early decline in albumin is associated with worse prognosis.

Critical Care Medicine
Seoul National University (KR), University of California, San Francisco (US), Kyungpook National University Hospital (KR), Seoul National University Hospital (KR), Seoul National University Bundang Hospital (KR), Kyungpook National University (KR), SNUH SMG-SNU Boramae Medical Center (KR), The Catholic University of Korea Yeouido St. Mary's Hospital (KR), Hallym University Sacred Heart Hospital (KR), Korea University Guro Hospital (KR), Keimyung University (KR), Catholic University of Korea (KR)
Good health and well-being
Acute Kidney Injury Research
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon